In the BioHarmony Drug Report Database
Sebelipase alfa
Kanuma (sebelipase alfa) is an enzyme pharmaceutical. Sebelipase alfa was first approved as Kanuma on 2015-08-28. It has been approved in Europe to treat inborn errors lipid metabolism.
Trade Name
|
Kanuma |
|---|---|
Common Name
|
sebelipase alfa |
ChEMBL ID
|
CHEMBL3039537 |
Indication
|
inborn errors lipid metabolism |
Drug Class
|
Enzymes |
Image (chem structure or protein)
